Nephroblastoma (Wilms' tumour)

 


·         Originates from the embryonal kidney

·         Pathologically contains renal tissue with various degrees of differentiation

·         Affects about 1 in 10,000 live births

·         60% present before the age of three years

·         10% tumours are bilateral

·         The presentation is with an:

o        Abdominal mass (90%)

o        Abdominal pain (20%)

o        Haematuria (30%)

A young boy with a left nephroblastoma

·         Diagnosis can be confirmed by CT scan

·         40% have metastatic spread at presentation but do not prevent cure

·         Treatment is with nephrectomy and postoperative chemotherapy and radiotherapy

·         Stage 1 disease (localised to kidney) has 3-year survival of >80%

·         Stage 4 disease (haematogenous spread) has 3-year survival less than 30%

CT scan showing a right nephroblastoma

Neuroblastoma

·         Arises from neural crest tissue - usually adrenal medulla or sympathetic ganglia

·         Show a range of malignancy from benign ganglioneuroma to malignant neuroblastoma

·         Tumours in children are usually malignant

·         75% are abdominal

·         25% arise in thorax, pelvis or neck

·         Affects about 1 in 8,000 live births

·         Usually occur in first five years of life

·         Clinical presentation depends on site of tumour and presence of metastases

·         Bone and pulmonary metastases are relatively common

·         Symptoms often due to metastases include:

o        Pallor, weight loss, irritability (40%)

o        Limb pain and hypertension (15%)

o        Abdominal mass or pain (30%)

·         90% have increased urinary VMA and HVA

·         Pain abdominal x-ray often shows diffused speckled calcification

·         Diagnosis can be confirmed by CT scan

·         Treatment is with surgery and post-operative radiotherapy

·         Prognosis is best in children presenting before 2 years

·         Stage 1 disease (localised to kidney) has 3-year survival of >90%

·         Stage 4 disease (haematogenous spread) has 3-year survival less than 30%


 

Useful Link